About
Pharmacovigilance and ADR Reporting
Course Introduction
About this course
Pharmacovigilance & ADR Reporting focuses on the science and activities related to the detection, assessment, understanding, and prevention of adverse drug reactions (ADRs) and other drug-related problems. It plays a crucial role in ensuring medication safety throughout a drug’s lifecycle, from clinical development to post-marketing surveillance. Pharmacovigilance systems help healthcare professionals and regulatory authorities identify potential safety signals, evaluate risks, and ensure the safe and rational use of medicines in clinical practice.
Pharmacovigilance and Adverse Drug Reaction (ADR) reporting form the post-marketing safety backbone of modern pharmaceutical practice — combining surveillance, signal detection, and structured reporting into the system that protects patients across the medicine lifecycle.
This course builds foundational competence in pharmacovigilance and ADR reporting — covering surveillance systems, ADR classification, causality assessment, regulatory reporting, and the documentation discipline that anchors effective drug safety practice.
🎯 Built for clinical readiness. Concise, structured, and skill-focused — designed to translate directly into safer, more confident clinical practice.
What this programme covers
Scope of the Course
What this course covers
The scope of Pharmacovigilance & ADR Reporting includes monitoring drug safety, identifying adverse drug reactions, signal detection, risk assessment, and regulatory reporting requirements. It also covers the structure of pharmacovigilance systems, spontaneous reporting programs, global safety databases, causality assessment methods, and regulatory frameworks used to maintain drug safety in healthcare systems.
🧠
Why this scope matters
This course builds foundational competence in pharmacovigilance and ADR reporting — covering surveillance systems, ADR classification, causality assessment, regulatory reporting, and the documentation discipline that anchors effective drug safety practice.
Learning objectives
Course Objectives & Outcomes
What you will achieve
By the end of this course, learners will have built core clinical competencies directly applicable to everyday practice — translating into safer, more confident, more effective patient care.
Each outcome below targets a specific dimension of pharmacovigilance practice — building the systematic approach required for confident ADR reporting.
By the end of this course, learners will be able to:
01
To understand the principles and importance of pharmacovigilance in ensuring drug safety
02
To develop knowledge of adverse drug reaction identification and reporting procedures
03
To understand causality assessment, signal detection, and risk evaluation methods
04
To familiarize learners with regulatory guidelines and pharmacovigilance reporting systems
05
To prepare learners for professional roles related to drug safety monitoring and pharmacovigilance operations
Sharper surveillance. Earlier signals. Safer medicines.
Build clinical confidence one skill at a time.
Who can enroll
Who Can Enroll
Built for these learners
This course is designed for healthcare learners and professionals seeking practical, skill-focused clinical training.
This course is built for pharmacy students, hospital pharmacists, drug safety professionals, regulatory affairs staff, and clinical professionals involved in pharmacovigilance.
Designed for these learners
🧑⚕️
01
Pharmacy students including B.Pharm, M.Pharm, Pharm.D
👨⚕️
02
Life science graduates
👩⚕️
03
Clinical research professionals
🦹
04
Healthcare practitioners involved in medication safety monitoring
💊
05
Individuals seeking to build foundational knowledge
🎓
06
Career opportunities in pharmacovigilance
📝
07
Drug safety reporting
Sharper Skills. Stronger Practice.
Take the next step in your clinical journey with structured, skill-focused training.
Programme Certification
Your certificate
Upon successful completion of this programme, you will receive a digital certificate recognising your achievement and the competencies you have acquired throughout the course.
Certificates for TerraLeap programmes are issued and signed by authorised TerraLeap representatives. For programmes delivered in collaboration with universities, institutions, or industry organisations, certificates are jointly issued and co-signed by authorised representatives of both TerraLeap and the respective partner.
Each certificate carries a unique Certificate ID and QR code to enable instant authenticity verification — making it easy to share with employers, licensing bodies, or professional networks as evidence of your learning.
Note on scope. TerraLeap certificates confirm successful completion of the respective programme and recognise your professional development and continuing education. They do not constitute a professional licence or regulatory authorisation unless explicitly stated in the programme description.
TERRALEAP
Certificate ID
TL-2026-AB7K3X9P
Official
Seal
Certificate of Completion
Successfully Completed
Awarded in recognition of academic achievement
This is to certify that
XXXXX
has successfully completed the prescribed course of study, demonstrating commitment, diligence, and proficiency in
Pharmacovigilance and ADR Reporting
and is hereby awarded this certificate by TerraLeap, recognising the candidate's mastery of the syllabus and successful evaluation.